Defining the molecular pathological events underlying the selective vulnerability of neuron populations associated with cognitive decline during the progression of Alzheimer's disease (AD) is crucial for biomarker development and therapeutics to slow/prevent the onset of this disease. Project 4 of this Program Project provided novel insights into the neurotrophic mechanisms underlying the survival of the cholinergic basal forebrain (CBF) neurons, which provide the cholinergic innervation the entire cortical mantle and hippocamppus, play a key role in memory and attention, their degeneration is associated with clinical severity and disease duration as well as targets of drug therapies during the onsest of AD. This area gained greater importance following a recent Phase 1 clinical trial demonstrating that ex vivo NGF (CBF neuron survival factor) gene therapy improves cognition and induces CBF neuronal sprouting in mild AD. Our striking findings showing a shift in the balance between cell survival and cell death mechanisms, a phenotypic reduction in trkA and p75NTR but not ChAT containing CBF neurons as well as a shift in the ratio of 3Rtau/4Rtau within CBF neurons in people with mild cogntivie impairment suggest that subtle alterations in the balance of cellular molecules underlie CBF neuron death. The pro-apoptotic effect(s) of p75NTRmediated proNGF signaling is, in part, dependent on its interactions with the chaperone neurotensin receptor, sortilin, which we have shown to increase in the AD cortex (see Preliminary data) suggest a role in CBF cell death in AD. Project Specific Aims will test the following hypothesis: 1 A. that cortical sortilin level is increased in the MCI and AD compared to NCI cortex. 1B. that TrkA is increased while p75NTR, sortilin and proNGF protein levels remain stable in hippocampus in MCI (see Preliminary data). 2A. that there are greater numbers of ChAT only immunopositive nucleus basalis neurons compared of co-labeled for ChAT and NGF receptors. 2B. that classes of genes for cell survival signaling, regulation of transcription, and cholinergic neurotransmission are differentially altered in ChAT only compared to those co-labeled also for ChAT and TrkA or p75NTR during the progression of AD. 3. that alteration in the expression ratio of 3Rtau/4Rtau isoforms is an early marker in the evolution of CBF NFTs during the progression of AD. These findings will directly translate to the development of new drugs for CBF cell survival in MCI and AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG014449-15
Application #
8377073
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
2014-01-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
15
Fiscal Year
2012
Total Cost
$491,381
Indirect Cost
$112,780
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Tiernan, Chelsea T; Combs, Benjamin; Cox, Kristine et al. (2016) Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport. Exp Neurol 283:318-29
Mufson, Elliott J; Ikonomovic, Milos D; Counts, Scott E et al. (2016) Molecular and cellular pathophysiology of preclinical Alzheimer's disease. Behav Brain Res 311:54-69
Rosa, Elyse; Mahendram, Sujeivan; Ke, Yazi D et al. (2016) Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease. Neurobiol Aging 48:135-142
Kirkwood, Caitlin M; MacDonald, Matthew L; Schempf, Tadhg A et al. (2016) Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration. J Neuropathol Exp Neurol 75:175-82
Mufson, Elliott J; Malek-Ahmadi, Michael; Snyder, Noelle et al. (2016) Braak stage and trajectory of cognitive decline in noncognitively impaired elders. Neurobiol Aging 43:101-10
Strupp, Barbara J; Powers, Brian E; Velazquez, Ramon et al. (2016) Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease. Curr Alzheimer Res 13:97-106
Mizukami, Katsuyoshi; Akatsu, Hiroyasu; Abrahamson, Eric E et al. (2016) Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. Neuropathology 36:135-45
Gorelick, Philip B; Counts, Scott E; Nyenhuis, David (2016) Vascular cognitive impairment and dementia. Biochim Biophys Acta 1862:860-8
Tiernan, Chelsea T; Ginsberg, Stephen D; Guillozet-Bongaarts, Angela L et al. (2016) Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease. Neurobiol Aging 42:80-90
Beck, John S; Mufson, Elliott J; Counts, Scott E (2016) Evidence for Mitochondrial UPR Gene Activation in Familial and Sporadic Alzheimer's Disease. Curr Alzheimer Res 13:610-4

Showing the most recent 10 out of 245 publications